• Tue news: Pfizer explores sale of hospital drugs unit. FDA declines full approval of Ocaliva. AZ better than expected Q3 results. Pfizer, Lilly telehealth platforms draw scrutiny. 23andMe cutting lays off 40%. See more on our front page

Pfizer, GSK RSV shots get tepid recommendations from CDC advisory panel

cafead

Administrator
Staff member
  • cafead   Jun 22, 2023 at 10:52: AM
via The Centers for Disease Control and Prevention's (CDC's) Advisory Committee on Immunization Practices (ACIP) has recommended that adults 60 and older—in consultation with their doctors—receive vaccines to prevent lower respiratory tract disease caused by respiratory syncytial virus (RSV).

The thumbs-up, however, was anything but enthusiastic.

Instead of telling seniors that they should be vaccinated, the panel has said that people may get a dose of GSK’s Arexvy or Pfizer’s Abrysvo if it is right for them.

article source